Growth Metrics

Invivyd (IVVD) Change in Account Payables (2021 - 2025)

Invivyd posted quarterly Change in Account Payables of -$4.2 million for Q4 2025, up 41.76% year-on-year from -$3.0 million in Q4 2024, and down 1847.71% on a QoQ basis from -$218000.0 in Q3 2025.

Invivyd (IVVD) has 5 years of Change in Account Payables data on file, last reported at -$4.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 41.76% year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 32.52% YoY), and the FY2025 full-year result was $3.2 million, up 32.52% from the prior year.
  • Change in Account Payables for Q4 2025 stood at -$4.2 million, down from -$218000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $12.9 million in Q1 2022 and bottomed at -$14.7 million in Q4 2022.
  • The 5-year median for Change in Account Payables is -$611500.0 (2021), against an average of $271750.0.
  • Peak annual rise in Change in Account Payables reached 443.75% in 2024, while the deepest fall reached 500.58% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$11.3 million in 2021, then slumped by 30.07% to -$14.7 million in 2022, then surged by 91.73% to -$1.2 million in 2023, then plunged by 500.58% to -$7.3 million in 2024, then soared by 41.76% to -$4.2 million in 2025.
  • The last three Change in Account Payables figures came in at -$4.2 million (Q4 2025), -$218000.0 (Q3 2025), and $9.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -3.26 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 35.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Invivyd 208.38 Mn -18.31 Mn - -4.25 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4.25 Mn
Dec 31, 2025 -4.25 Mn
Sep 30, 2025 -218,000.00
Sep 30, 2025 -218,000.00
Jun 30, 2025 9.31 Mn
Jun 30, 2025 9.31 Mn
Mar 31, 2025 -1.64 Mn
Mar 31, 2025 -1.64 Mn
Dec 31, 2024 -7.29 Mn
Dec 31, 2024 -7.29 Mn
Sep 30, 2024 10.31 Mn
Sep 30, 2024 10.31 Mn
Jun 30, 2024 6.19 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 -6.79 Mn
Mar 31, 2024 -6.79 Mn
Dec 31, 2023 -1.21 Mn
Dec 31, 2023 -1.21 Mn
Sep 30, 2023 5.06 Mn
Sep 30, 2023 5.06 Mn
Jun 30, 2023 -1.80 Mn
Jun 30, 2023 -1.80 Mn
Mar 31, 2023 4.43 Mn
Mar 31, 2023 4.43 Mn
Dec 31, 2022 -14.67 Mn
Dec 31, 2022 -14.67 Mn
Sep 30, 2022 1.92 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 -4.45 Mn
Jun 30, 2022 -4.45 Mn
Mar 31, 2022 12.90 Mn
Mar 31, 2022 12.90 Mn
Dec 31, 2021 -11.28 Mn
Dec 31, 2021 -11.28 Mn
Sep 30, 2021 6.75 Mn
Sep 30, 2021 6.75 Mn
Jun 30, 2021 -1.01 Mn
Jun 30, 2021 -1.01 Mn
Mar 31, 2021 3.16 Mn
Mar 31, 2021 3.16 Mn